Published in Cancer on July 01, 2004
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol (2005) 7.57
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst (2009) 5.62
Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg (2009) 5.38
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Estimating average annual per cent change in trend analysis. Stat Med (2009) 3.54
Anaplastic lymphoma kinase: signalling in development and disease. Biochem J (2009) 3.05
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer (2016) 2.91
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst (2015) 2.81
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood (2012) 2.65
Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc (2008) 2.46
The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg (2007) 2.36
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer (2013) 2.17
Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med (2008) 2.14
Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc (2008) 2.01
Declining death rates reflect progress against cancer. PLoS One (2010) 1.91
African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark (2007) 1.76
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst (2009) 1.75
Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression. BMC Cancer (2005) 1.73
Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol (2010) 1.70
Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health (2014) 1.68
Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med (2011) 1.68
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med (2006) 1.65
The paradox of response and survival in cancer therapeutics. Blood (2005) 1.63
Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health (2006) 1.62
Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer (2010) 1.62
Wnt signalling in lung development and diseases. Respir Res (2006) 1.55
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis (2008) 1.55
Interventions to enhance breast cancer screening, diagnosis, and treatment among racial and ethnic minority women. Med Care Res Rev (2007) 1.51
Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences. Health Serv Res (2007) 1.50
The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) (2006) 1.50
Von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1. Eur Urol (2008) 1.48
The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw (2009) 1.44
Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev (2009) 1.44
Quality of life among Latina breast cancer patients: a systematic review of the literature. J Cancer Surviv (2011) 1.42
Transcriptomes of human prostate cells. BMC Genomics (2006) 1.42
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial. World J Gastroenterol (2010) 1.36
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
Cancer survivors in the United States: a review of the literature and a call to action. Int J Med Sci (2012) 1.30
Smoking-attributable cancer mortality in California, 1979-2005. Tob Control (2010) 1.29
Work disability associated with cancer survivorship and other chronic conditions. Psychooncology (2008) 1.28
Impact of cancer therapies on ovarian reserve. Fertil Steril (2011) 1.28
ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg (2005) 1.27
Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer (2009) 1.26
Cancer patient navigator tasks across the cancer care continuum. J Health Care Poor Underserved (2012) 1.26
Who provides psychosocial follow-up care for post-treatment cancer survivors? A survey of medical oncologists and primary care physicians. J Clin Oncol (2012) 1.26
Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid (2010) 1.25
Reducing disparities in the burden of cancer: the role of patient navigators. PLoS Med (2006) 1.24
Patient barriers to follow-up care for breast and cervical cancer abnormalities. J Womens Health (Larchmt) (2013) 1.23
Geographic disparities in colorectal cancer survival. Int J Health Geogr (2009) 1.21
Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control (2011) 1.20
Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer (2011) 1.18
Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study. PLoS One (2010) 1.18
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat (2011) 1.16
Breast and prostate cancer survival in Michigan: can geographic analyses assist in understanding racial disparities? Cancer (2009) 1.16
Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila) (2011) 1.16
Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis (2007) 1.15
The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Native American breast cancer survivors' physical conditions and quality of life. Cancer (2010) 1.15
Cancer survivorship, health insurance, and employment transitions among older workers. Inquiry (2009) 1.15
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol (2008) 1.14
Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer. Breast Cancer Res (2010) 1.14
Ethnicity and persistent symptom burden in breast cancer survivors. J Cancer Surviv (2009) 1.13
Cancer screening and risk factor rates among American Indians. Am J Public Health (2005) 1.12
Primary care physicians and disparities in colorectal cancer screening in the elderly. Health Serv Res (2012) 1.12
GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med (2012) 1.12
Navigating Latinas with breast screen abnormalities to diagnosis: the Six Cities Study. Cancer (2012) 1.12
Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest (2005) 1.11
Educating Hispanic women about breast cancer prevention: evaluation of a home-based promotora-led intervention. J Womens Health (Larchmt) (2010) 1.11
High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer (2005) 1.09
Healthy colon, healthy life (colon sano, vida sana): colorectal cancer screening among Latinos in Santa Clara, California. J Cancer Educ (2010) 1.08
Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation. Phys Med Biol (2008) 1.08
The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol (2009) 1.08
A randomized controlled trial of a multilevel intervention to increase colorectal cancer screening among Latino immigrants in a primary care facility. J Gen Intern Med (2010) 1.07
Atrophic gastritis in young children and adolescents. J Clin Pathol (2005) 1.07
Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study. Support Care Cancer (2006) 1.07
Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc (2006) 1.07
Communication, decision making, and cancer: what African Americans want physicians to know. J Palliat Med (2008) 1.07
Developing a community action plan to eliminate cancer disparities: lessons learned. Prog Community Health Partnersh (2011) 1.06
Patients' barriers to receipt of cancer care, and factors associated with needing more assistance from a patient navigator. J Natl Med Assoc (2011) 1.06
Spatial association of racial/ethnic disparities between late-stage diagnosis and mortality for female breast cancer: where to intervene? Int J Health Geogr (2011) 1.06
Long-term effects of cancer survivorship on the employment of older workers. Health Serv Res (2008) 1.06
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol (2009) 1.05
Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare. Health Serv Res (2007) 1.04
The use of sociocultural constructs in cancer screening research among African Americans. Cancer Control (2009) 1.04
Fighting cancer with fitness: dietary outcomes of a randomized, controlled lifestyle change intervention in healthy African-American women. Prev Med (2006) 1.04
Long-term employment effects of surviving cancer. J Health Econ (2011) 1.03
First national survival data for colorectal cancer among Saudis between 1994 and 2004: what's next? BMC Public Health (2013) 1.03
The religiosity/spirituality of Latina breast cancer survivors and influence on health-related quality of life. Psychooncology (2009) 1.03
Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies. PLoS One (2014) 1.03
Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study. Cancer (2011) 1.02
Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC). J Transl Med (2004) 1.02
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Cancer statistics, 2003. CA Cancer J Clin (2003) 13.46
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Trends in the leading causes of death in the United States, 1970-2002. JAMA (2005) 8.20
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77
Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res (2006) 7.67
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist (2007) 6.03
Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med (2002) 5.97
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Deaths: leading causes for 2000. Natl Vital Stat Rep (2002) 5.16
Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol (2010) 5.11
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control (2007) 4.61
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood (2008) 4.41
Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer (2002) 3.89
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Estimating average annual per cent change in trend analysis. Stat Med (2009) 3.54
The way forward. Lancet (2007) 3.28
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol (2011) 3.11
Deaths: leading causes for 2001. Natl Vital Stat Rep (2003) 3.11
The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries. J Natl Cancer Inst (2009) 3.09
Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist (2003) 3.04
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief (2011) 2.99
Cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer (2008) 2.80
Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer (2004) 2.70
Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer (2008) 2.67
Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol (2005) 2.67
Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst (2010) 2.59
Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol (2003) 2.56
Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst (2002) 2.54
Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am J Prev Med (2008) 2.50
Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer (2005) 2.41
Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36
Deaths: injuries, 2002. Natl Vital Stat Rep (2006) 2.30
Deaths: final data for 2001. Natl Vital Stat Rep (2003) 2.26
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev (2007) 2.21
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol Biomarkers Prev (2005) 2.19